Roehl & Yi Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$962K Buy
7,486
+2,523
+51% +$295K 0.32% 67
2026
Q1
$597K Buy
4,963
+422
+9% +$48.7K 0.22% 90
2025
Q4
$478K Sell
4,541
-31
-0.7% -$2.91K 0.19% 102
2025
Q3
$384K Sell
4,572
-28
-0.6% -$2.31K 0.17% 106
2025
Q2
$364K Sell
4,600
-1,525
-25% -$121K 0.19% 108
2025
Q1
$550K Buy
6,125
+117
+2% +$10.9K 0.3% 82
2024
Q4
$598K Buy
+6,008
New +$619K 0.33% 76

Other funds holding MRK

Roehl & Yi Investment Advisors's MRK Position: Q2 2026 in Review

Roehl & Yi Investment Advisors increased its Merck (MRK) stake by 51% in Q2 2026, buying an estimated $295K and bringing the position to 7,486 shares worth $962K. The position accounts for 0.32% of the portfolio, ranked #67.

Roehl & Yi Investment Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,828 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Roehl & Yi Investment Advisors held 7,486 shares of Merck worth $962K as of Q2 2026.
  • Roehl & Yi Investment Advisors bought 2,523 Merck shares in Q2 2026, an estimated $295K.
  • Merck made up 0.32% of Roehl & Yi Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Roehl & Yi Investment Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,828 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Roehl & Yi Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.